GlassBury AI combines agentic patient matching with culturally sensitive community education to eliminate healthcare disparities. By pairing AI with expert-curated workshops, we build the trust necessary to connect underrepresented patients with life-changing clinical trials.

Double the Words, Double the Wits: Why Being Bilingual Really Does Seem to Delay Dementia

This is, in a simplified way, what speaking two languages does to your brain. And for years, scientists have been noticing something fascinating about this dual-language metropolis: its inhabitants seem to enjoy a longer lease on their cognitive prime, particularly when it comes to the specter of dementia.

Read More

Remote Relief: How Virtual Support Boosts Mood and Confidence for Families Facing Dementia

Dementia is a health crisis sweeping the globe. Experts estimate that roughly 50 million people worldwide are currently living with this condition. That enormous figure is expected to nearly double to 80 million by 2030 and potentially surpass 150 million by 2050. Alarmingly, a new dementia diagnosis happens every three seconds.

Read More
Medical Innovation, GlassBuryAI, AI Corey Hubbard Medical Innovation, GlassBuryAI, AI Corey Hubbard

AI Revolution: Decoding Alzheimer’s Before Symptoms Start

For decades, we’ve treated Alzheimer’s like a collapsing building. We usually don’t call the engineers until the roof is already caving in—when memory loss is so severe that it disrupts daily life. The medical criteria from 1984, which set the standard for diagnosis for a long time, were built on this "end-stage" philosophy. By the time we diagnosed the disease, the damage was often irreparable.

Read More